Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical and Corporate Update
businessNews

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical and Corporate Update

Mar 29, 2021

MONTREAL and CHARLOTTE, N.C., March 29, 2021 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the fourth quarter and year…


Continue Reading

Related Articles

businessNews WallSt

Apple loses legal challenge to Swatch using Steve Jobs' 'One more thing' phrase

J Mar, 2021
businessNews WallSt

Jeffrey Epstein friend Ghislaine Maxwell faces new charges in sex crimes case

J Mar, 2021
businessNews WallSt

Stock market news live updates: Stocks mixed as Archegos margin call ricochets across markets; Suez ship freed

J Mar, 2021

News You Missed

zerohedge

Should Those Responsible For The Minimum Wage Law Be Indicted As Criminals

Mar 29, 2021 HEDGE
businessNews WallSt

Apple loses legal challenge to Swatch using Steve Jobs' 'One more thing' phrase

Mar 29, 2021 HEDGE
WallSt

US prosecutors's case against Ghislaine Maxwell widens as new charges brought

Mar 29, 2021 HEDGE
WallSt

ABB and AWS team up to create an EV fleet management platform

Mar 29, 2021 HEDGE
HEDGE accordingly